Copyright
©The Author(s) 2019.
World J Gastroenterol. Aug 21, 2019; 25(31): 4405-4413
Published online Aug 21, 2019. doi: 10.3748/wjg.v25.i31.4405
Published online Aug 21, 2019. doi: 10.3748/wjg.v25.i31.4405
Studies | Comparisons | Outcome | Result | Performance |
Sighinolfi et al[21], 2017 | Fukouka, AGA, and Sendai Criteria1 | Pancreatic Cyst with invasive cancer | AGA ROC 0.76, Fukouka ROC 0.78, Sendai ROC 0.65 (P < 0.001) | AGA and Fukuoka guidelines with higher diagnostic accuracy for neoplastic cysts compared to Sendai |
Xu et al[20], 2017 | AGA, Fukouka, and American College of Radiology1 | Advanced neoplasia (HGD or cancer) in resected pancreatic cysts | (Sen, Spec, PPV, NPV) AGA; 7.3%, 88.2%, 10%, and 84.1% Fukouka: 73.2%, 45.6%, 19.5%, 90.4% ACR: 53.7%, 61%, 19.8%, and 88% | AGA with higher specificity, but lower sensitivity than Fukuoka and ACR |
Ma et al[22], 2016 | AGA and Fukouka2 | Advanced neoplasia (HGD or cancer) in resected pancreatic cysts | Fukouka: 28.2%, 95.8%, 74.1%, 75.9% AGA: 35.2.%, 94%, 71.4%, 77.5% | No significant difference between the two guidelines |
Singhi et al, 2016 | AGA | Advanced neoplasia (HGD or cancer) | AGA: 62%, 79%, 57%, 82% | Low accuracy of AGA guidelines and continued surveillance of benign lesions (i.e., SCAs) |
Lekkerkerker et al[23], 2017 | Fukuoka, AGA, European Guidelines | Advanced neoplasia (in patients with suspected IPMN) | Accuracy Fukuoka: 54% AGA: 59% European: 53% | AGA guidelines would have rec’d against surgery in most patients with benign lesions and would have missed significantly more HGD/CA |
- Citation: Hasan A, Visrodia K, Farrell JJ, Gonda TA. Overview and comparison of guidelines for management of pancreatic cystic neoplasms. World J Gastroenterol 2019; 25(31): 4405-4413
- URL: https://www.wjgnet.com/1007-9327/full/v25/i31/4405.htm
- DOI: https://dx.doi.org/10.3748/wjg.v25.i31.4405